| Robyn Young, MD | |
|
800 W Magnolia Ave, Fort Worth, TX 76104-4611 | |
| (817) 759-7000 | |
| (817) 759-7027 |
| Full Name | Robyn Young |
|---|---|
| Gender | Female |
| Speciality | Medical Oncology |
| Experience | 34 Years |
| Location | 800 W Magnolia Ave, Fort Worth, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962452474 | NPI | - | NPPES |
| 1048803-03 | Medicaid | TX | |
| 1048803-04 | Medicaid | TX | |
| 8M2990 | Other | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | J0389 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical City Weatherford | Weatherford, TX | Hospital |
| Texas Health Harris Methodist Hospital Southwest F | Fort worth, TX | Hospital |
| Texas Health Harris Methodist Hospital Fort Worth | Fort worth, TX | Hospital |
| Lake Granbury Medical Center | Granbury, TX | Hospital |
| Baylor Scott & White All Saints Medical Center Fort Worth | Fort worth, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oncology-hematology Consultants Pa | 5496646382 | 56 |
News Archive
Soligenix, Inc., a late-stage biotechnology company, announced today that it has received a Hong Kong patent which addresses its Lipid Polymer Micelle (LPM™) technology for the improved oral delivery of drugs. The issued Hong Kong patent, HK 1071054, entitled "Stabilized Reverse Micelle Compositions and Uses Thereof" covers lipid structures (reverse micelles) that promote the intestinal absorption of peptides and other sensitive drugs that cannot otherwise be given orally.
Using computational modeling, researchers at Carnegie Mellon University, the Colorado School of Mines and the University of California, Davis have come up with a design for a better liposome. Their findings, while theoretical, could provide the basis for efficiently constructing new vehicles for nanodrug delivery.
With a single stimulatory molecule, human insulin-producing beta cell replication can be sustained for at least four weeks in a mouse model of diabetes, according to researchers at the University of Pittsburgh School of Medicine in Diabetes, a journal of the American Diabetes Association.
Anthem Blue Cross and Blue Shield, Connecticut's largest health insurer and a favorite target of advocates for more stringent regulation of rate increases, is seeking to raise premiums by 12.9 percent next year for more than 45,000 individual-market customers, including some whose plans were the subject of a controversial request that got denied last year.
› Verified 2 days ago
| Entity Name | Oncology-hematology Consultants Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629021159 PECOS PAC ID: 5496646382 Enrollment ID: O20040322000664 |
News Archive
Soligenix, Inc., a late-stage biotechnology company, announced today that it has received a Hong Kong patent which addresses its Lipid Polymer Micelle (LPM™) technology for the improved oral delivery of drugs. The issued Hong Kong patent, HK 1071054, entitled "Stabilized Reverse Micelle Compositions and Uses Thereof" covers lipid structures (reverse micelles) that promote the intestinal absorption of peptides and other sensitive drugs that cannot otherwise be given orally.
Using computational modeling, researchers at Carnegie Mellon University, the Colorado School of Mines and the University of California, Davis have come up with a design for a better liposome. Their findings, while theoretical, could provide the basis for efficiently constructing new vehicles for nanodrug delivery.
With a single stimulatory molecule, human insulin-producing beta cell replication can be sustained for at least four weeks in a mouse model of diabetes, according to researchers at the University of Pittsburgh School of Medicine in Diabetes, a journal of the American Diabetes Association.
Anthem Blue Cross and Blue Shield, Connecticut's largest health insurer and a favorite target of advocates for more stringent regulation of rate increases, is seeking to raise premiums by 12.9 percent next year for more than 45,000 individual-market customers, including some whose plans were the subject of a controversial request that got denied last year.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robyn Young, MD 800 W Magnolia Ave, Fort Worth, TX 76104-4611 Ph: (817) 759-7000 | Robyn Young, MD 800 W Magnolia Ave, Fort Worth, TX 76104-4611 Ph: (817) 759-7000 |
News Archive
Soligenix, Inc., a late-stage biotechnology company, announced today that it has received a Hong Kong patent which addresses its Lipid Polymer Micelle (LPM™) technology for the improved oral delivery of drugs. The issued Hong Kong patent, HK 1071054, entitled "Stabilized Reverse Micelle Compositions and Uses Thereof" covers lipid structures (reverse micelles) that promote the intestinal absorption of peptides and other sensitive drugs that cannot otherwise be given orally.
Using computational modeling, researchers at Carnegie Mellon University, the Colorado School of Mines and the University of California, Davis have come up with a design for a better liposome. Their findings, while theoretical, could provide the basis for efficiently constructing new vehicles for nanodrug delivery.
With a single stimulatory molecule, human insulin-producing beta cell replication can be sustained for at least four weeks in a mouse model of diabetes, according to researchers at the University of Pittsburgh School of Medicine in Diabetes, a journal of the American Diabetes Association.
Anthem Blue Cross and Blue Shield, Connecticut's largest health insurer and a favorite target of advocates for more stringent regulation of rate increases, is seeking to raise premiums by 12.9 percent next year for more than 45,000 individual-market customers, including some whose plans were the subject of a controversial request that got denied last year.
› Verified 2 days ago
Charles A Carlton, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1622 8th Avenue, Suite 110, Fort Worth, TX 76104 Phone: 817-926-2561 Fax: 817-921-3708 | |
Paul J Garcia, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5701 Bryant Irvin Rd, Suite 302, Fort Worth, TX 76132 Phone: 817-294-9000 Fax: 817-294-9010 | |
Stevan A Gonzalez, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1250 8th Ave, Suite 515, Fort Worth, TX 76104 Phone: 817-922-4675 Fax: 817-922-4645 | |
Jeremy Aaron Ross, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 800 W Magnolia Ave, Fort Worth, TX 76104 Phone: 817-759-7000 Fax: 817-759-7027 | |
Elie B Choufani, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 601 W Terrell Ave, Fort Worth, TX 76104 Phone: 817-852-8305 | |
Syed Hadi Jafri, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1300 W Terrell Ave Fl 2, Fort Worth, TX 76104 Phone: 817-820-4906 Fax: 817-820-4815 | |
Cheryl K Mcdonald, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1125 College Ave, Fort Worth, TX 76104 Phone: 817-810-9810 Fax: 817-810-9815 |